Security key
05153U107
Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA)
CUSIP: 05153U107
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.00001 per share
- Shares outstanding
- 96,296,293
- Total 13F shares
- 27,066,492
- Share change
- +1,996,893
- Total reported value
- $334,426,517
- Put/Call ratio
- 100%
- Price per share
- $12.35
- Number of holders
- 59
- Value change
- +$24,980,886
- Number of buys
- 39
- Number of sells
- 17
Report period
Q2 2023
Institutions
59
Top holders
10
AURA full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Aura Biosciences, Inc. SEC filings
Aura Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05153U107
Recent filing periods:
Top shareholders of AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Matrix Capital Management Company, LP |
13F
|
Company |
5.6%
|
5,362,870
|
$49,767,434 | — | 31 Mar 2023 | |
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
|
Company · 10%+ Owner |
3.2%
|
3,039,892
|
$28,210,198 | — | 31 Mar 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.8%
|
2,710,000
|
$25,148,800 | — | 31 Mar 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
2,525,830
|
$23,439,702 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.6%
|
2,502,221
|
$23,220,611 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.4%
|
1,331,100
|
$12,352,607 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
1,048,587
|
$9,730,887 | — | 31 Mar 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.1%
|
1,019,757
|
$9,463,345 | — | 31 Mar 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.88%
|
843,446
|
$7,827,179 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.74%
|
710,605
|
$6,595,000 | — | 31 Mar 2023 | |
| Regency Capital Management Inc.\DE |
13F
|
Company |
0.56%
|
543,675
|
$5,045,304 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.54%
|
516,042
|
$4,788,870 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.48%
|
457,908
|
$4,249,386 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
0.37%
|
356,847
|
$3,311,540 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.36%
|
348,555
|
$3,234,590 | — | 31 Mar 2023 | |
| Decheng Capital Management III (Cayman), LLC |
13F
|
Company |
0.3%
|
293,333
|
$2,722,130 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.3%
|
288,498
|
$2,677,261 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
195,421
|
$1,813,507 | — | 31 Mar 2023 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
0.18%
|
171,377
|
$1,590,379 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
72,593
|
$673,664 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
64,659
|
$600,035 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.07%
|
63,413
|
$588,473 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.06%
|
54,291
|
$504,000 | — | 31 Mar 2023 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.06%
|
53,956
|
$500,712 | — | 31 Mar 2023 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.05%
|
51,991
|
$482,476 | — | 31 Mar 2023 | |
| Cadmus Rich |
3/4/5
|
Chief Medical Officer, Head of R&D |
—
mixed-class rows
|
111,203
mixed-class rows
|
$448,579 | — | 19 Jan 2023 | |
| Mark de Rosch |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
123,635
mixed-class rows
|
$448,059 | — | 19 Jan 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
41,093
|
$381,343 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
34,417
|
$319,390 | — | 31 Mar 2023 | |
| TBH Global Asset Management, LLC |
13F
|
Company |
0.03%
|
33,097
|
$307,143 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
31,281
|
$290,000 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
29,787
|
$276,000 | — | 31 Mar 2023 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.02%
|
23,744
|
$220,344 | — | 31 Mar 2023 | |
| WATER ISLAND CAPITAL LLC |
13F
|
Company |
0.02%
|
23,666
|
$219,620 | — | 31 Mar 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
0.02%
|
21,772
|
$202,044 | — | 31 Mar 2023 | |
| MARTINGALE ASSET MANAGEMENT L P |
13F
|
Company |
0.02%
|
20,354
|
$188,886 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
18,498
|
$171,000 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
15,362
|
$142,559 | — | 31 Mar 2023 | |
| LEVIN CAPITAL STRATEGIES, L.P. |
13F
|
Company |
0.02%
|
15,000
|
$139,200 | — | 31 Mar 2023 | |
| Mariner, LLC |
13F
|
Company |
0.01%
|
13,922
|
$129,000 | — | 31 Mar 2023 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
13,562
|
$125,855 | — | 31 Mar 2023 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.01%
|
11,659
|
$108,196 | — | 31 Mar 2023 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
11,416
|
$105,940 | — | 31 Mar 2023 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.01%
|
11,201
|
$104,000 | — | 31 Mar 2023 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.01%
|
11,026
|
$102,321 | — | 31 Mar 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.01%
|
10,800
|
$100,224 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
10,343
|
$95,983 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
10,100
|
$94,000 | — | 31 Mar 2023 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
8,794
|
$81,608 | — | 31 Mar 2023 | |
| Christopher Brett Primiano |
3/4/5
|
Chief Business Officer |
—
mixed-class rows
|
46,250
mixed-class rows
|
$66,863 | — | 28 Oct 2021 |
Institutional Holders of Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) as of Q2 2023
As of 30 Jun 2023,
Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,066,492 shares.
The largest 10 holders included
Matrix Capital Management Company, LP, Medicxi Ventures Management (Jersey) Ltd, EVENTIDE ASSET MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, Rock Springs Capital Management LP, and Nantahala Capital Management, LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
57
Q2 2023 holders
59
Holder diff
2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.